Mednax Inc buy Macquarie
Start price
16.12.24
/
50%
€13.80
Target price
16.12.25
€17.13
Performance (%)
36.23%
End price
17.12.25
€18.80
Summary
This prediction ended on 17.12.25 with a price of €18.80. With a performance of 36.23% the BUY prediction by Macquarie was a big success. Macquarie has a follow-up prediction for Mednax Inc where he still thinks Mednax Inc is a Buy. Macquarie has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mednax Inc | 1.579% | 1.579% | 87.379% |
| iShares Core DAX® | 0,41 % | 8,82 % | 12,26 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % | 44,02 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % | 48,04 % |
| iShares S&P 500 | 2,44 % | 7,93 % | 33,00 % |
Comments by Macquarie for this prediction
In the thread Mednax Inc diskutieren
Pediatrix Medical Group, Inc. (NYSE: MD) is now covered by analysts at Macquarie. They set an "outperform" rating and a $18.00 price target on the stock.
Ratings data for MD provided by MarketBeat
In the thread Trading Mednax Inc
Die von Macquarie gewählte maximale Laufzeit wurde überschritten